ELIZABETH MILAZZO: Open Payments
NPI 1427376755 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 16 payments from 9 companies in 2025. Trend: 2023 $309 · 2024 $489 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $95 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $44 |
| Inspire Medical Systems, Inc. | 2 | $31 |
| Genentech USA, Inc. | 1 | $23 |
| KARL STORZ Endoscopy-America | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, INSPIRE, Xolair, NEFFY.
Industry payments across AL — which companies pay providers there.
